Intuitive Surgical, Inc., which makes the da Vinci surgical robot, has agreed to pay $450 million to settle an antitrust class action brought by hospitals. On November 20, 2026, the hospitals asked the U.S. District Court for the Northern District of California to preliminarily approve the deal in In re Da Vinci Surgical Robot Antitrust Litigation, No. 4:21-cv-03825-AMO. The motion is set for a hearing on April 1, 2027 before U.S. District Judge Araceli Martínez-Olguín in Oakland.
Besides the cash, Intuitive agreed to five years of changes meant to open up competition in refurbishing EndoWrist instruments and servicing da Vinci robots. The hospitals’ economics expert values those changes at about $1.06 billion to $1.93 billion. The settlement was signed October 16, 2026, after a two-day mediation, and still needs the court’s approval.
Free settlement alerts
Get notified when new class actions open to claims
Join thousands of readers who get the latest class action settlements you may qualify for — delivered straight to your inbox.
Status
Preliminary Approval Requested
Motion filed Nov. 20, 2026 · hearing April 1, 2027
Settlement
$450 million cash + 5 years of structural relief
Split pro rata by EndoWrist and da Vinci service purchases · no money reverts to Intuitive
Can I Claim?
Hospitals only — claims not open
Patients and surgeons are not class members
The court certified the class on March 31, 2025. It covers all entities that bought EndoWrist instruments and da Vinci service from Intuitive in the United States from May 21, 2017 through December 31, 2021, except hospitals run by the Departments of Defense and Veterans Affairs. That is about 2,200 hospitals and surgery centers. Three hospital systems opted out after class notice went out in early 2026, and the settlement does not propose a second chance to opt out.
Patients who had robotic surgery are not in the class, and the case does not involve claims that the robot injured anyone. The settlement expressly leaves out unrelated product-liability and personal-injury claims.
The hospitals sued in 2021 under Sections 1 and 2 of the Sherman Act. They claimed Intuitive used tying, exclusive dealing and monopolization to control the markets for da Vinci service and for EndoWrist repair and replacement. That included use-count limits on EndoWrist instruments and contract terms discouraging hospitals from using refurbished instruments or outside service companies. Intuitive disputed the claims and argued its limits reflected engineering and patient-safety concerns. No court has found Intuitive liable.
The case was headed for trial. The court denied Intuitive’s motion to dismiss in January 2022, ruled at summary judgment in March 2024 that the da Vinci robot and EndoWrists are separate products, and certified the class in 2025. The Ninth Circuit declined to hear Intuitive’s appeal of class certification.
Intuitive would pay $450 million into an interest-bearing fund within 30 days of preliminary approval. For five years after the settlement takes effect, it also agreed to:
- Not void service contracts, stop doing business with U.S. customers or treat them as in breach for using FDA-cleared EndoWrists remanufactured by third parties.
- Keep an authorization process for refurbishing and resetting the use counters of eligible EndoWrists still owned by their original buyers, with access to the technical specifications needed for safety testing.
- Not threaten to void robot warranties, stop servicing robots or stop selling EndoWrists because an authorized or FDA-cleared instrument was used, unless there is damage, malfunction or a patient-safety danger.
- Not block qualifying third parties from supplying refurbished EndoWrists, or stop hospitals from sending used instruments to them.
- Develop and pilot a program letting trained hospital technicians and independent service organizations do preventive maintenance and field repairs on da Vinci X and Xi robots. The pilot is projected to launch in the first quarter of 2028 and run 18 to 24 months.
Intuitive can still promote its own products, offer lawful pricing and make genuine product improvements. In exchange, class members would release claims tied to the conduct in the case, including related claims that arise during the five-year period.
After court-approved fees and costs, the fund would be paid pro rata to eligible class members that file valid claims, based on the plaintiffs’ expert’s damages calculation for each member’s EndoWrist and da Vinci service purchases. A.B. Data, the proposed claims administrator, would send claim forms pre-filled with each member’s purchase data from Intuitive’s records where possible, with a unique ID for filing online. Claims could also be mailed. Members that disagree with their data could submit records. Payments would go out by wire transfer or check. Any money left after distribution would go to a court-approved charitable recipient, not back to Intuitive.
Class counsel plan to ask for up to one-third of the fund in attorneys’ fees and up to $10 million in expenses, plus $100,000 service awards for each of the three hospital plaintiffs. The court decides those amounts after class members can object.
The motion compares the fund with the damages estimates in the case. The plaintiffs’ expert put single damages through 2023 at roughly $1.28 billion to $3.46 billion across EndoWrists and service, so the fund is about 13% to 35% of that range. Intuitive’s expert calculated about $420 million.
The court will consider preliminary approval at the April 1, 2027 hearing. Under the proposed schedule, notice and the claims period would begin 30 days after a preliminary approval order. Objections would be due 80 days after the order, and the final approval hearing would come at least 130 days after it. Class members would get notice by email and mail, and details will be posted on the official case website.
Can patients who had da Vinci robotic surgery get money from this settlement?
No. The class is made up of hospitals, surgery centers and other entities that bought EndoWrist instruments and da Vinci service directly from Intuitive in the U.S. from May 21, 2017 through December 31, 2021. Patients and surgeons are not class members, and the case is not about injuries from surgery.
How would the $450 million da Vinci settlement be divided?
After court-approved attorneys' fees, expenses and service awards, the fund would be split pro rata among eligible class members that file valid claims, based on the plaintiffs' expert's damages calculation for each member's EndoWrist and da Vinci service purchases. Claim forms would be pre-filled with purchase data from Intuitive's records where possible. No money would return to Intuitive.
What changes would Intuitive make under the da Vinci settlement?
For five years after the settlement takes effect, Intuitive would let customers use FDA-cleared third-party remanufactured EndoWrists without losing service or warranty coverage, keep an authorization process for refurbishing and resetting the use counters of eligible EndoWrists, not block qualifying third-party refurbishers, and pilot a program letting trained hospital technicians and independent service companies maintain and repair da Vinci X and Xi robots, with the pilot projected to launch in early 2028.
When will the da Vinci settlement be approved?
The motion for preliminary approval is set for a hearing on April 1, 2027. If the court grants it, notice and the claims period would start about 30 days later, and a final approval hearing would follow at least 130 days after the preliminary approval order.
For more class actions keep scrolling below.
Status
Preliminary approval requested · hearing April 1, 2027
Case Title
In re Da Vinci Surgical Robot Antitrust Litigation
Case Number
4:21-cv-03825-AMO
Court
U.S. District Court, Northern District of California (Oakland)
Settlement
$450 million + structural relief
Class Period
May 21, 2017 – December 31, 2021